Erratum to vasohibin 2 promotes lymphangiogenesis of lung squamous cell carcinoma through snail-dependent vascular endothelial growth factor-D (VEGF-D) signaling pathway
Erratum to: Ann Transl Med 2022;10:39
This article (1) titled “Vasohibin 2 promotes lymphangiogenesis of lung squamous cell carcinoma through snail-dependent vascular endothelial growth factor-D (VEGF-D) signaling pathway” (doi: 10.21037/atm-21-4865), unfortunately contains errors in Figure 4 and Figure 5. In Figure 4, the image of cell invasion, H520CTRL group in Figure 4D was wrongly renamed as H520OV-VASH2 + sh-Snail group. In Figure 5, the image of tube formation, H520OV-VASH2 + sh-Snail group in Figure 5B was misused. The corrected version of Figure 4 and Figure 5 can be found below.
Corrected Figure 4:
Corrected Figure 5:
The authors regret for the unintentional errors made during the assembly of Figure 4 and Figure 5, and this correction does not adversely affect the interpretation of data or overall conclusions reported in the study.
Click here to view the updated version of the article.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Liu P, Zhang R, Han L, et al. Vasohibin 2 promotes lymphangiogenesis of lung squamous cell carcinoma through snail-dependent vascular endothelial growth factor-D (VEGF-D) signaling pathway. Ann Transl Med 2022;10:39. [Crossref] [PubMed]
